Headlines

MID WEB AD_Vertical left side 426 pixels (height) x 170 pixels (width).gif

ARMMS-T2D: MBS produces lasting diabetes remission

People with type 2 diabetes were much more likely to achieve remission after metabolic-bariatric surgery (MBS) than after intensive medical and lifestyle management, according to a long-term study by researchers from the University of Oklahoma. They also identified patient characteristics linked to remission and to the likelihood of diabetes returning. The study found that 58% of participants assigned to metabolic-bariatric surgery achieved diabetes remission, compared with 3

ARMMS-T2D: MBS produces lasting diabetes remission

Lower cancer risk after MBS regardless of age or sex

WHO does not recommend pharmacological treatment, bariatric surgery or weight-loss devices for children

Research

ŌURA establishes clinical trial to examine how Oura Ring data relate to outcomes from GLP-1 and MBS

ŌURA has announced the launch of SMART-BMI, its first clinical trial, in collaboration with UC San Diego Health, that will examine how sleep, heart rate, and activity data from Oura Ring relate to outcomes from GLP-1 treatment and bariatric surgery. The multi-year study is the latest addition to Oura’s growing work in healthcare research, scientific validation, and outcomes measurement, led by the Office of Regulatory and Clinical Affairs (ORCA), which was built over the past

Boehringer Ingelheim establishes Metabolic Matters Steering Committee for obesity and related liver diseases

Boehringer Ingelheim has formed the Metabolic Matters Steering Committee, a multidisciplinary effort focused on advancing outcomes for conditions, such as obesity, that impact metabolic health. The Committee is comprised of leading clinicians, advocates and experts who have committed to identifying opportunities to close gaps in diagnosis and care, improve patient-provider dialogue, and advance public understanding of metabolic health. Obesity and other cardiometabolic condit

GLP-1 drugs help patients lose regained weight after bariatric surgery

People who regain weight after bariatric surgery may benefit from glucagon-like peptide-1 receptor agonists (GLP-1s), according to a study involving Regenstrief Institute, Indiana University, Purdue University and University of Florida researchers. The study found that patients prescribed these medications lost more of their regained weight over six and 12 months than comparable patients who did not use them. Bariatric surgery can produce substantial weight loss, but some pat

ARMMS-T2D: MBS produces lasting diabetes remission

MBS can restore immune cell function affected by obesity

Maynooth University (MU) research led by the Department of Biology's Dr Ciara Flynn, working within the research group of Prof Andrew Hogan at the Kathleen Lonsdale Institute for Human Health Research, has found that obesity can impair key immune cells that help protect the body against infection and cancer. The study also found that bariatric surgery can reverse many of these immune cell defects, restoring their ability to respond more effectively to threats. “The findings p

Vogenx initiates EMERGE study of Mizagliflozin for post-bariatric hypoglycaemia

Vogenx has initiated the EMERGE (VGX-001-013) study - its Phase 2b clinical trial evaluating mizagliflozin for the treatment of post-bariatric hypoglycaemia (PBH). There are currently no therapeutics approved by the FDA for the treatment of PBH. EMERGE is a randomised, placebo-controlled, double-blind, parallel-group Phase 2b study designed to enrol approximately 36 adults who underwent bariatric surgery more than 12 months prior and who experience recurrent reactive hypoglyc

Lower cancer risk after MBS regardless of age or sex

Metabolic and bariatric surgery (MBS) reduces the risk of obesity-related cancer regardless of sex and age, according to a large Nordic registry study led by researchers at Karolinska Institutet. The results strengthen knowledge about the cancer-preventive effects of MBS for several cancers linked to obesity. "We found that the reduction in cancer risk after obesity surgery was similar across age groups and between women and men, suggesting that the long-term health benefits

General dietary interventions may matter more than specific habits before MBS

People preparing for metabolic and bariatric surgery (MBS) may eat quite differently from one another, but those differences do not necessarily translate into different measures of cardiometabolic health, according to a Concordia study. The researchers say the findings could help health professionals and patients inform lifestyle and eating habits in the lead-up to surgery, and earlier. Simon Bacon (Credit: Concordia University) Researchers identified two distinct dietary pro

Medtronic and Styker announce strategic investments in Cornerstone Robotics and CMR Surgical

Medtech giants, Medtronic and Stryker, have announced strategic investments in Cornerstone Robotics and CMR Surgical (CMR), respectively, as the companies seek to consolidate their positions in the robotic surgery market. Cornerstone Robotics' Sentire surgical system In early September, Medtronic revealed they had signed a strategic partnership with Cornerstone Robotics, in which Medtronic made an approximately $700 million investment includes rights to distribute Cornerstone

WHO does not recommend pharmacological treatment, bariatric surgery or weight-loss devices for children

The World Health Organization (WHO) has released its first guidelines addressing the sharp rise in obesity among children and adolescents, setting out how health systems and health workers can deliver timely, evidence-based and people-centred care. In the guidelines, WHO does not recommend pharmacological treatment, bariatric surgery or weight-loss devices for children aged 0–9 years. In 2024, 170 million children and adolescents aged 5–19 years were living with obesity, incl

Improve the evidence based across the board for GLP-1 RA use in women

The second of a series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2), presenters discussed the wide-ranging issues relating to use of GLP-1 RA drug use in women. The paper’s authors, including Professor Paul Franks, Lund University, Helsingborg Hospital, Helsingborg, Sweden and Professor Claire Meek, Leicester Diabetes Research Centre and Leicester NIHR Biomedical Research Centre, Leice

No link between semaglutide and pancreatic cancer

There is no link between semaglutide (a glucagon-like peptide-1 receptor agonist, GLP-1RA) use and pancreatic cancer using nationwide registry data from Denmark, Sweden and Norway, according to at the Annual Meeting of The European Association for the Study of Diabetes (EASD). This regulator-mandated post authorisation study, funded by Novo Nordisk, was presented by Professor Anton Pottegård, University of Southern Denmark, Odense, Denmark, and colleagues. “This comprehensive

Industry

Medtronic and Styker announce strategic investments in Cornerstone Robotics and CMR Surgical

Medtronic unveils Touch Surgery Aide - the next-generation compute platform for the OR

Shimadzu Medical Systems launches release of the FLUOROspeed X1 edition ST

First commercial EndoZip ESG cases performed in France

All caught up?

See all news

New: Directory

Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.

Browse directory

Events

Headlines

ARMMS-T2D: MBS produces lasting diabetes remission

ARMMS-T2D: MBS produces lasting diabetes remission

ARMMS-T2D: MBS produces lasting diabetes remission

Lower cancer risk after MBS regardless of age or sex

WHO does not recommend pharmacological treatment, bariatric surgery or weight-loss devices for children

Research

ŌURA establishes clinical trial to examine how Oura Ring data relate to outcomes from GLP-1 and MBS

Boehringer Ingelheim establishes Metabolic Matters Steering Committee for obesity and related liver diseases

GLP-1 drugs help patients lose regained weight after bariatric surgery

ARMMS-T2D: MBS produces lasting diabetes remission

MBS can restore immune cell function affected by obesity

Vogenx initiates EMERGE study of Mizagliflozin for post-bariatric hypoglycaemia

Lower cancer risk after MBS regardless of age or sex

General dietary interventions may matter more than specific habits before MBS

Medtronic and Styker announce strategic investments in Cornerstone Robotics and CMR Surgical

WHO does not recommend pharmacological treatment, bariatric surgery or weight-loss devices for children

Improve the evidence based across the board for GLP-1 RA use in women

No link between semaglutide and pancreatic cancer

Industry

Medtronic and Styker announce strategic investments in Cornerstone Robotics and CMR Surgical

Medtronic unveils Touch Surgery Aide - the next-generation compute platform for the OR

Shimadzu Medical Systems launches release of the FLUOROspeed X1 edition ST

First commercial EndoZip ESG cases performed in France

All caught up?

New: Directory

Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.

Events

(See all)

ALRSGBI Annunal Meeting 2026

6th LIBSS

Obesity Days

4th IFSO MENAC Meeting

London International Robotic Surgery Conference

6th London International Bariatric Surgery Symposium (LIBSS)

Tweets

Back to Top